Sanara MedTech Inc.
SMTI
$33.95
$3.4311.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.23% | -10.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.23% | -10.92% | |||
| Cost of Revenue | 5.57% | -18.42% | |||
| Gross Profit | 10.62% | -10.21% | |||
| SG&A Expenses | 0.53% | -2.07% | |||
| Depreciation & Amortization | -0.91% | 2.07% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.36% | -7.75% | |||
| Operating Income | 98.50% | -53.89% | |||
| Income Before Tax | 42.78% | -107.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 42.78% | -107.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 1,900.00% | -99.88% | |||
| Net Income | 42.89% | -129.25% | |||
| EBIT | 98.50% | -53.89% | |||
| EBITDA | 213.32% | -282.39% | |||
| EPS Basic | 43.17% | -128.29% | |||
| Normalized Basic EPS | 43.39% | -45.62% | |||
| EPS Diluted | 43.17% | -128.29% | |||
| Normalized Diluted EPS | 43.39% | -45.62% | |||
| Average Basic Shares Outstanding | 0.50% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.50% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||